Topic: How To Invest

Q: Hi, Pat. This cannabis stock has a big greenhouse being built. What do you think of its prospects?

Article Excerpt

A: Emerald Health Therapeutics Inc., $3.57, symbol EMH on the Toronto Venture Exchange (Shares Outstanding: 137.1 million; Market cap: $494.3 million; www.emeraldhealth.ca), produces and sells cannabis for the medical and recreational cannabis markets. The company’s head office is in Victoria, B.C. Emerald entered the medical marijuana market through a reverse takeover of T-Bird Pharma Inc. in 2014. In 2015, it changed its name to Emerald Health Therapeutics. The company’s 50%-owned Pure Sunfarms joint venture in B.C. is now completing a 1.1-million-square-feet greenhouse (see below); and its Agro-Biotech operation in Quebec is completing a 75,000-square-feet indoor facility. Portions of both facilities are already in commercial production. Emerald also owns Northern Vine Labs, a research and development facility that offers laboratory services for the cannabis industry. The lab is licensed to import and export cannabis oil for the purpose of product innovation and development. The company has filed 17 U.S. patent applications for its precise method of calibrating marijuana dosages. Its exclusive Defined Dose formulation process…